Possible role of edotecarin, a novel topoisomerase I inhibitor, in therapy-related myelodysplastic syndrome. uri icon

Overview

publication date

  • January 1, 2007

Research

keywords

  • Antineoplastic Agents
  • Carbazoles
  • Indoles
  • Myelodysplastic Syndromes
  • Topoisomerase I Inhibitors

Identity

Scopus Document Identifier

  • 34247255977

Digital Object Identifier (DOI)

  • 10.1080/10428190600968350

PubMed ID

  • 17325867

Additional Document Info

volume

  • 48

issue

  • 1